Effects of eicosapentaenoic acid on cardiac SR Ca2+-release and ryanodine receptor function

Cardiovascular Research

Volumn 60, Issue 2, 2003, Pages 337-346

  Swan, J S ^a   Dibb, K ^b   Negretti, N ^c   O'Neill, S C ^b   Sitsapesan, R ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

Arrhythmias; Calcium (cellular); Excitation contraction coupling; Ion channels

Indexed keywords

ANTIARRHYTHMIC AGENT; CALCIUM CHANNEL; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; ICOSAPENTAENOIC ACID; ION CHANNEL; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; RYANODINE RECEPTOR; SATURATED FATTY ACID;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART ARRHYTHMIA; HEART MUSCLE; HEART MUSCLE FIBER MEMBRANE POTENTIAL; NONHUMAN; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEINASE INHIBITION; RAT; SARCOPLASMIC RETICULUM; VOLTAGE CLAMP;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CALCIUM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DEPRESSION, CHEMICAL; EICOSAPENTAENOIC ACID; ISOQUINOLINES; PATCH-CLAMP TECHNIQUES; RATS; RATS, INBRED STRAINS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SHEEP; SULFONAMIDES;

EID: 0242542527     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00545-5     Document Type: Article

References (31)

1. Billman G.E., Hallaq H., Leaf A. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc. Natl. Acad. Sci. U. S. A. 91:1994;4427-4430.
2. Kang J.X., Xiao Y.F., Leaf A. Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc. Natl. Acad. Sci. U. S. A. 92:1995;3997-4001.
3. Negretti N., Perez M.R., Walker D., O'Neill S.C. Inhibition of sarcoplasmic reticulum function by poly-unsaturated fatty acids in intact, isolated myocytes from rat ventricular muscle. J. Physiol. 523(2):2000;367-375.
4. Ford D.A., Hazen S.L., Saffitz J.E., Gross R.W. The rapid and reversible activation of a calcium-independent plasmalogen-selective phospholipase A2 during myocardial ischemia. J. Clin. Invest. 88:1991;331-335.
5. Hazen S.L., Ford D.A., Gross R.W. Activation of a membrane-associated phospholipase A2 during rabbit myocardial ischemia which is highly selective for plasmalogen substrate. J. Biol. Chem. 266:1991;5629-5633.
6. McLennan P.L., Bridle T.M., Abeywardena M.Y., Charnock J.S. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am. Heart J. 123:1992;1555-1561.
7. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 106:2002;2747-2757.
8. Nair S.S., Leitch J., Falconer J., Garg M.L. Cardiac (n-3) non-esterified fatty acids are selectively increased in fish oil-fed pigs following myocardial ischemia. J. Nutr. 129:1999;1518-1523.
9. Picq M., Dubois M., Grynberg A., Lagarde M., Prigent A.F. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes. J. Mol. Cell. Cardiol. 28:1996;2151-2161.
10. Negretti N., O'Neill S.C. The positive lusitropic effects of n-3 polyunsaturated fatty acids is inhibited by H89 in isolated rat ventricular myocytes. J. Physiol. 543.P:2002;80P-81P.
11. Takasago T., Imagawa T., Shigekawa M. Phosphorylation of the cardiac ryanodine receptor by cAMP-dependent protein kinase. J. Biochem. (Tokyo). 106:1989;872-877.
12. Hain J., Onoue H., Mayrleitner M., Fleischer S., Schindler H. Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from cardiac muscle. J. Biol. Chem. 270:1995;2074-2081.
13. Uehara A., Yasukochi M., Mejia-Alvarez R., Fill M., Imanaga I. Gating kinetics and ligand sensitivity modified by phosphorylation of cardiac ryanodine receptors. Pflugers Arch. 444:2002;202-212.
14. Swan J.S., O'Neill S.C., Sitsapesan R. Inhibition of cardiac and skeletal ryanodine receptors by the polyunsaturated fatty acid eicosapentaenoic acid (EPA). J. Physiol. 544P:2003;54P. [Abstract].
15. 2+ release. Biophys. J. 84(2):2003;257a. [Abstract].
16. Eisner D.A., Nichols C.G., O'Neill S.C., Smith G.L., Valdeolmillos M. The effects of metabolic inhibition on intracellular calcium and pH in isolated rat ventricular cells. J. Physiol. 411:1989;393-418.
17. Varro A., Negretti N., Hester S.B., Eisner D.A. An estimate of the calcium content of the sarcoplasmic reticulum in rat ventricular myocytes. Pflugers Arch. 423:1993;158-160.
18. Hussain M., Drago G.A., Bhogal M., Colyer J., Orchard C.H. Effects of the protein kinase A inhibitor H-89 on Ca2+ regulation in isolated ferret ventricular myocytes. Pflugers Arch. 437:1999;529-537.
19. Sitsapesan R., Montgomery R.A.P., MacLeod K.T., Williams A.J. Sheep cardiac sarcoplasmic reticulum calcium release channels: modification of conductance and gating by temperature. J. Physiol. 434:1991;469-488.
20. Chan W.M., Welch W., Sitsapesan R. Structural factors that determine the ability of adenosine and related compounds to activate the cardiac ryanodine receptor. Br. J. Pharmacol. 130:2000;1618-1626.
21. 2+ release and sarcoplasmic reticulum calcium content in rat ventricular myocytes. J. Physiol. 502:1997;471-479.
22. O'Neill S.C., Perez M.R., Hammond K.E., Sheader E.A., Negretti N. Direct and indirect modulation of rat cardiac sarcoplasmic reticulum function by n-3 polyunsaturated fatty acids. J. Physiol. 538:2002;179-184.
23. Mirnikjoo B., Brown S.E., Kim H.F., Marangell L.B., Sweatt J.D., Weeber E.J. Protein kinase inhibition by omega-3 fatty acids. J. Biol. Chem. 276:2001;10888-10896.
24. Li Y., Kranias E.G., Mignery G.A., Bers D.M. Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes. Circ. Res. 90:2002;309-316.
25. Takasago T., Imagawa T., Shigekawa M. Phosphorylation of the cardiac ryanodine receptor by cAMP-dependent protein kinase. J. Biochem. (Tokyo). 106:1989;872-877.
26. Uehara A., Yasukochi M., Mejia-Alvarez R., Fill M., Imanaga I. Gating kinetics and ligand sensitivity modified by phosphorylation of cardiac ryanodine receptors. Pflugers Arch. 444:2002;202-212.
27. Zamudio F.Z., Conde R., Arévalo C., Becerril B., Martin B.M., Valdivia H.H.et al. The mechanism of inhibition of ryanodine receptor channels by Imperatoxin I, a heterodimeric protein from the scorpion Pandinus imperator. J. Biol. Chem. 272:1997;11886-11894.
28. 2+ release channel by arachidonic acid. J. Mol. Cell. Cardiol. 28:1996;43-51.
29. Pound E.M., Kang J.X., Leaf A. Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. J. Lipid Res. 42:2001;346-351.
30. McGarry S.J., Williams A.J. Adenosine discriminates between the caffeine and adenine nucleotide sites on the sheep cardiac sarcoplasmic reticulum calcium-release channel. J. Membr. Biol. 137:1994;169-177.
31. Sitsapesan R., Williams A.J. Modification of the conductance and gating properties of ryanodine receptors by suramin. J. Membr. Biol. 153:1996;93-103.